All posts by: Michael Zand

About Michael Zand

Cynata and apceth in deal to develop stem cell-based therapeutics – The Pharma Letter (registration)

Continue reading

2016-05-09 NEWS

Cynata and apceth in deal to develop stem cell-based therapeutics
The Pharma Letter (registration)
Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has entered into a worldwide license option agreement with German biopharma firm apceth. The agreement will combine Cynata’s Cymerus technology with genetic …

Continue reading

2016-05-07 NEWS

Tech Times

Skin-To-Eye Stem Cell Transplant Partially Restores Eyesight Of Woman With Age-Related Macular Degeneration
Tech Times
Partial restoration of vision was successfully carried out by scientists using skin-to-eye stem cell transplant. Japanese scientists reported that they were able to successfully complete a skin-to-eye stem cell transplant to a 70-year-old woman
Japanese scientists have used skin cells to restore a patient’s vision for the first timeScienceAlert
1st skin-to-eye cell transplant partially restores AMD patient’s visionRT
Japanese Scientists Have Restored a Patient’s Vision With Skin Cells For the First TimeThe Science Explorer
Metro
all 6 news articles »